Sean Wieland
Stock Analyst at Piper Sandler
(1.32)
# 3,519
Out of 4,915 analysts
29
Total ratings
40%
Success rate
-0.78%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Overweight | $25 → $40 | $19.54 | +104.71% | 2 | Feb 28, 2025 | |
| OMCL Omnicell | Upgrades: Overweight | $70 → $39 | $31.01 | +25.77% | 11 | Nov 3, 2023 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $7.35 | +1,532.65% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $66.18 | -90.93% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $58.75 | -25.11% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $185.86 | +24.29% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.21 | +3,936.06% | 5 | Feb 25, 2021 |
Privia Health Group
Feb 28, 2025
Maintains: Overweight
Price Target: $25 → $40
Current: $19.54
Upside: +104.71%
Omnicell
Nov 3, 2023
Upgrades: Overweight
Price Target: $70 → $39
Current: $31.01
Upside: +25.77%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $7.35
Upside: +1,532.65%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $66.18
Upside: -90.93%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $58.75
Upside: -25.11%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $185.86
Upside: +24.29%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.21
Upside: +3,936.06%